Loading company…
Theremia uses machine learning to support precision medicine for central nervous system conditions.
Theremia develops precision medicine tools for central nervous system diseases, with a focus on mental health. It works with biotech companies to analyze patient data and support treatment development. Founded in 2024 and based in Paris, France, it raised EUR 3 million in seed funding in November 2024, co-led by Eurazeo and Salica Investments, with Entrepreneur First and Bpifrance participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in